Advantis Stock Price, News & Analysis
Company Description
Advantis (OTC Link: ADVT) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $9.8K.
ADVT stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of ADVT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Advantis (ADVT) stock last traded at $0.0000. At a market capitalization of $9.8K, ADVT is classified as a micro-cap stock with approximately 878.5M shares outstanding.
Latest News
Advantis has 1 recent news article. View all ADVT news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ADVT Company Profile & Sector Positioning
Advantis (ADVT) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ADVT often look at related companies in the same sector, including WEST IS BRANDS INC (WIBFF), Cbd Denver Inc (CBDD), Can B Corp (CANB), Software Effective Solutions (SFWJ), and Galexxy Holdings Inc (GXXY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ADVT's relative position within its industry.